nodes	percent_of_prediction	percent_of_DWPC	metapath
Trazodone—ABCB1—peripheral nervous system neoplasm	0.306	1	CbGaD
Trazodone—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.0607	0.132	CbGbCtD
Trazodone—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.0607	0.132	CbGbCtD
Trazodone—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0455	0.0987	CbGbCtD
Trazodone—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0319	0.0691	CbGbCtD
Trazodone—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0319	0.0691	CbGbCtD
Trazodone—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.0279	0.0604	CbGbCtD
Trazodone—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.0279	0.0604	CbGbCtD
Trazodone—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0221	0.0479	CbGbCtD
Trazodone—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0209	0.0453	CbGbCtD
Trazodone—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0192	0.0415	CbGbCtD
Trazodone—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0191	0.0414	CbGbCtD
Trazodone—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0177	0.0385	CbGbCtD
Trazodone—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0136	0.0295	CbGbCtD
Trazodone—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0127	0.0275	CbGbCtD
Trazodone—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0125	0.027	CbGbCtD
Trazodone—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0085	0.0184	CbGbCtD
Trazodone—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00815	0.0177	CbGbCtD
Trazodone—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00801	0.0174	CbGbCtD
Trazodone—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00747	0.0162	CbGbCtD
Trazodone—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00509	0.011	CbGbCtD
Trazodone—HTR2A—phrenic nerve—peripheral nervous system neoplasm	0.00365	0.242	CbGeAlD
Trazodone—HTR2A—trigeminal nerve—peripheral nervous system neoplasm	0.00134	0.0884	CbGeAlD
Trazodone—HTR2A—vagus nerve—peripheral nervous system neoplasm	0.00125	0.0827	CbGeAlD
Trazodone—HTR2C—ganglion—peripheral nervous system neoplasm	0.000961	0.0636	CbGeAlD
Trazodone—HTR2A—cranial nerve—peripheral nervous system neoplasm	0.000952	0.063	CbGeAlD
Trazodone—HTR2A—pons—peripheral nervous system neoplasm	0.000941	0.0623	CbGeAlD
Trazodone—SLC6A4—ganglion—peripheral nervous system neoplasm	0.000911	0.0603	CbGeAlD
Trazodone—HTR1A—ganglion—peripheral nervous system neoplasm	0.000808	0.0535	CbGeAlD
Trazodone—HTR2A—nerve—peripheral nervous system neoplasm	0.000488	0.0323	CbGeAlD
Trazodone—HTR2A—ganglion—peripheral nervous system neoplasm	0.000482	0.0319	CbGeAlD
Trazodone—HTR2C—brainstem—peripheral nervous system neoplasm	0.000418	0.0276	CbGeAlD
Trazodone—SLC6A4—brainstem—peripheral nervous system neoplasm	0.000396	0.0262	CbGeAlD
Trazodone—HTR1A—brainstem—peripheral nervous system neoplasm	0.000351	0.0233	CbGeAlD
Trazodone—ADRA1A—brainstem—peripheral nervous system neoplasm	0.000324	0.0214	CbGeAlD
Trazodone—HRH1—trigeminal ganglion—peripheral nervous system neoplasm	0.000283	0.0188	CbGeAlD
Trazodone—ADRA2A—trigeminal ganglion—peripheral nervous system neoplasm	0.000278	0.0184	CbGeAlD
Trazodone—Domperidone—ABCB1—peripheral nervous system neoplasm	0.000223	0.216	CrCbGaD
Trazodone—HTR2A—brainstem—peripheral nervous system neoplasm	0.000209	0.0139	CbGeAlD
Trazodone—CYP2D6—brainstem—peripheral nervous system neoplasm	0.000191	0.0126	CbGeAlD
Trazodone—Nefazodone—ABCB1—peripheral nervous system neoplasm	0.000185	0.18	CrCbGaD
Trazodone—HTR1A—cerebellum—peripheral nervous system neoplasm	0.000173	0.0115	CbGeAlD
Trazodone—Aripiprazole—ABCB1—peripheral nervous system neoplasm	0.000172	0.167	CrCbGaD
Trazodone—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000161	0.000766	CcSEcCtD
Trazodone—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000766	CcSEcCtD
Trazodone—Cerebrovascular accident—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000766	CcSEcCtD
Trazodone—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000161	0.000765	CcSEcCtD
Trazodone—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000161	0.000765	CcSEcCtD
Trazodone—Rash—Topotecan—peripheral nervous system neoplasm	0.000161	0.000765	CcSEcCtD
Trazodone—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000161	0.000764	CcSEcCtD
Trazodone—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000161	0.000764	CcSEcCtD
Trazodone—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000763	CcSEcCtD
Trazodone—Headache—Topotecan—peripheral nervous system neoplasm	0.00016	0.00076	CcSEcCtD
Trazodone—ADRA1A—cerebellum—peripheral nervous system neoplasm	0.00016	0.0106	CbGeAlD
Trazodone—Rash—Tretinoin—peripheral nervous system neoplasm	0.000159	0.000759	CcSEcCtD
Trazodone—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000159	0.000759	CcSEcCtD
Trazodone—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000159	0.000758	CcSEcCtD
Trazodone—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000159	0.000758	CcSEcCtD
Trazodone—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000159	0.000758	CcSEcCtD
Trazodone—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000159	0.000758	CcSEcCtD
Trazodone—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000159	0.000755	CcSEcCtD
Trazodone—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000754	CcSEcCtD
Trazodone—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000158	0.000754	CcSEcCtD
Trazodone—Headache—Tretinoin—peripheral nervous system neoplasm	0.000158	0.000754	CcSEcCtD
Trazodone—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000158	0.000753	CcSEcCtD
Trazodone—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000158	0.000751	CcSEcCtD
Trazodone—Constipation—Vincristine—peripheral nervous system neoplasm	0.000158	0.000751	CcSEcCtD
Trazodone—Pain—Vincristine—peripheral nervous system neoplasm	0.000158	0.000751	CcSEcCtD
Trazodone—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000751	CcSEcCtD
Trazodone—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000158	0.000751	CcSEcCtD
Trazodone—Rash—Melphalan—peripheral nervous system neoplasm	0.000157	0.000749	CcSEcCtD
Trazodone—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000157	0.000748	CcSEcCtD
Trazodone—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000157	0.000746	CcSEcCtD
Trazodone—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000156	0.000742	CcSEcCtD
Trazodone—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000156	0.000741	CcSEcCtD
Trazodone—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000156	0.000741	CcSEcCtD
Trazodone—Migraine—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000739	CcSEcCtD
Trazodone—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.000155	0.0103	CbGeAlD
Trazodone—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000154	0.000734	CcSEcCtD
Trazodone—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000153	0.000726	CcSEcCtD
Trazodone—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000152	0.000725	CcSEcCtD
Trazodone—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000152	0.000724	CcSEcCtD
Trazodone—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000152	0.000721	CcSEcCtD
Trazodone—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000152	0.000721	CcSEcCtD
Trazodone—Nausea—Topotecan—peripheral nervous system neoplasm	0.000151	0.00072	CcSEcCtD
Trazodone—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000151	0.000718	CcSEcCtD
Trazodone—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000151	0.000718	CcSEcCtD
Trazodone—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00015	0.000715	CcSEcCtD
Trazodone—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00015	0.000715	CcSEcCtD
Trazodone—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000714	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000149	0.000708	CcSEcCtD
Trazodone—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000706	CcSEcCtD
Trazodone—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000148	0.000706	CcSEcCtD
Trazodone—Nausea—Melphalan—peripheral nervous system neoplasm	0.000148	0.000705	CcSEcCtD
Trazodone—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000147	0.000698	CcSEcCtD
Trazodone—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000146	0.000695	CcSEcCtD
Trazodone—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000146	0.000695	CcSEcCtD
Trazodone—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000146	0.000695	CcSEcCtD
Trazodone—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000146	0.000693	CcSEcCtD
Trazodone—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000145	0.000688	CcSEcCtD
Trazodone—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000686	CcSEcCtD
Trazodone—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000143	0.000678	CcSEcCtD
Trazodone—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000142	0.000675	CcSEcCtD
Trazodone—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000141	0.000673	CcSEcCtD
Trazodone—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000141	0.000672	CcSEcCtD
Trazodone—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00014	0.000665	CcSEcCtD
Trazodone—Pain—Cisplatin—peripheral nervous system neoplasm	0.00014	0.000664	CcSEcCtD
Trazodone—Fluphenazine—ABCB1—peripheral nervous system neoplasm	0.000139	0.135	CrCbGaD
Trazodone—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000138	0.000654	CcSEcCtD
Trazodone—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000648	CcSEcCtD
Trazodone—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000136	0.000647	CcSEcCtD
Trazodone—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000136	0.000645	CcSEcCtD
Trazodone—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000135	0.00064	CcSEcCtD
Trazodone—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000135	0.00064	CcSEcCtD
Trazodone—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000134	0.000639	CcSEcCtD
Trazodone—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000638	CcSEcCtD
Trazodone—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000635	CcSEcCtD
Trazodone—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000133	0.000635	CcSEcCtD
Trazodone—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000133	0.000633	CcSEcCtD
Trazodone—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000133	0.00063	CcSEcCtD
Trazodone—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000626	CcSEcCtD
Trazodone—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000131	0.000625	CcSEcCtD
Trazodone—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000131	0.000624	CcSEcCtD
Trazodone—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00013	0.00062	CcSEcCtD
Trazodone—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.00013	0.000619	CcSEcCtD
Trazodone—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000129	0.000614	CcSEcCtD
Trazodone—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000129	0.000614	CcSEcCtD
Trazodone—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000128	0.00061	CcSEcCtD
Trazodone—Constipation—Etoposide—peripheral nervous system neoplasm	0.000128	0.000609	CcSEcCtD
Trazodone—Pain—Etoposide—peripheral nervous system neoplasm	0.000128	0.000609	CcSEcCtD
Trazodone—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000127	0.000603	CcSEcCtD
Trazodone—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000126	0.000601	CcSEcCtD
Trazodone—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000126	0.0006	CcSEcCtD
Trazodone—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.0006	CcSEcCtD
Trazodone—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000596	CcSEcCtD
Trazodone—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000593	CcSEcCtD
Trazodone—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000591	CcSEcCtD
Trazodone—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000587	CcSEcCtD
Trazodone—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000123	0.000587	CcSEcCtD
Trazodone—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000123	0.000584	CcSEcCtD
Trazodone—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000122	0.000582	CcSEcCtD
Trazodone—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000122	0.000581	CcSEcCtD
Trazodone—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000122	0.00058	CcSEcCtD
Trazodone—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000579	CcSEcCtD
Trazodone—ADRA2A—cerebellum—peripheral nervous system neoplasm	0.000121	0.00804	CbGeAlD
Trazodone—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000121	0.000575	CcSEcCtD
Trazodone—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000121	0.000574	CcSEcCtD
Trazodone—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00012	0.000572	CcSEcCtD
Trazodone—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000572	CcSEcCtD
Trazodone—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00012	0.000571	CcSEcCtD
Trazodone—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000119	0.000565	CcSEcCtD
Trazodone—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000564	CcSEcCtD
Trazodone—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000118	0.000563	CcSEcCtD
Trazodone—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000118	0.000563	CcSEcCtD
Trazodone—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000559	CcSEcCtD
Trazodone—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000117	0.000559	CcSEcCtD
Trazodone—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000117	0.000557	CcSEcCtD
Trazodone—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000555	CcSEcCtD
Trazodone—Rash—Vincristine—peripheral nervous system neoplasm	0.000116	0.000554	CcSEcCtD
Trazodone—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000116	0.000553	CcSEcCtD
Trazodone—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000552	CcSEcCtD
Trazodone—Headache—Vincristine—peripheral nervous system neoplasm	0.000116	0.00055	CcSEcCtD
Trazodone—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000114	0.000542	CcSEcCtD
Trazodone—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000541	CcSEcCtD
Trazodone—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000112	0.000532	CcSEcCtD
Trazodone—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000529	CcSEcCtD
Trazodone—Trifluoperazine—ABCB1—peripheral nervous system neoplasm	0.000111	0.108	CrCbGaD
Trazodone—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00011	0.000524	CcSEcCtD
Trazodone—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000524	CcSEcCtD
Trazodone—Nausea—Vincristine—peripheral nervous system neoplasm	0.00011	0.000522	CcSEcCtD
Trazodone—Flushing—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000521	CcSEcCtD
Trazodone—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000517	CcSEcCtD
Trazodone—Quetiapine—ABCB1—peripheral nervous system neoplasm	0.000108	0.104	CrCbGaD
Trazodone—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000107	0.000511	CcSEcCtD
Trazodone—Chills—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000504	CcSEcCtD
Trazodone—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000106	0.000504	CcSEcCtD
Trazodone—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000502	CcSEcCtD
Trazodone—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000501	CcSEcCtD
Trazodone—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000496	CcSEcCtD
Trazodone—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000104	0.000494	CcSEcCtD
Trazodone—HTR2A—cerebellum—peripheral nervous system neoplasm	0.000103	0.00683	CbGeAlD
Trazodone—Rash—Cisplatin—peripheral nervous system neoplasm	0.000103	0.00049	CcSEcCtD
Trazodone—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000103	0.000489	CcSEcCtD
Trazodone—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000102	0.000487	CcSEcCtD
Trazodone—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000484	CcSEcCtD
Trazodone—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000482	CcSEcCtD
Trazodone—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000482	CcSEcCtD
Trazodone—Tension—Epirubicin—peripheral nervous system neoplasm	0.000101	0.00048	CcSEcCtD
Trazodone—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000479	CcSEcCtD
Trazodone—Nervousness—Epirubicin—peripheral nervous system neoplasm	9.98e-05	0.000475	CcSEcCtD
Trazodone—Back pain—Epirubicin—peripheral nervous system neoplasm	9.94e-05	0.000473	CcSEcCtD
Trazodone—Dizziness—Etoposide—peripheral nervous system neoplasm	9.9e-05	0.000471	CcSEcCtD
Trazodone—Chills—Doxorubicin—peripheral nervous system neoplasm	9.8e-05	0.000466	CcSEcCtD
Trazodone—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	9.76e-05	0.000464	CcSEcCtD
Trazodone—Nausea—Cisplatin—peripheral nervous system neoplasm	9.7e-05	0.000461	CcSEcCtD
Trazodone—Vision blurred—Epirubicin—peripheral nervous system neoplasm	9.69e-05	0.000461	CcSEcCtD
Trazodone—Alopecia—Doxorubicin—peripheral nervous system neoplasm	9.65e-05	0.000459	CcSEcCtD
Trazodone—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	9.54e-05	0.000454	CcSEcCtD
Trazodone—Vomiting—Etoposide—peripheral nervous system neoplasm	9.51e-05	0.000453	CcSEcCtD
Trazodone—Anaemia—Epirubicin—peripheral nervous system neoplasm	9.5e-05	0.000452	CcSEcCtD
Trazodone—Agitation—Epirubicin—peripheral nervous system neoplasm	9.44e-05	0.000449	CcSEcCtD
Trazodone—Rash—Etoposide—peripheral nervous system neoplasm	9.43e-05	0.000449	CcSEcCtD
Trazodone—Dermatitis—Etoposide—peripheral nervous system neoplasm	9.43e-05	0.000448	CcSEcCtD
Trazodone—CYP2D6—cerebellum—peripheral nervous system neoplasm	9.41e-05	0.00623	CbGeAlD
Trazodone—Headache—Etoposide—peripheral nervous system neoplasm	9.37e-05	0.000446	CcSEcCtD
Trazodone—Flatulence—Doxorubicin—peripheral nervous system neoplasm	9.37e-05	0.000446	CcSEcCtD
Trazodone—Tension—Doxorubicin—peripheral nervous system neoplasm	9.33e-05	0.000444	CcSEcCtD
Trazodone—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	9.31e-05	0.000443	CcSEcCtD
Trazodone—Malaise—Epirubicin—peripheral nervous system neoplasm	9.27e-05	0.000441	CcSEcCtD
Trazodone—Clozapine—ABCB1—peripheral nervous system neoplasm	9.27e-05	0.0898	CrCbGaD
Trazodone—Nervousness—Doxorubicin—peripheral nervous system neoplasm	9.24e-05	0.000439	CcSEcCtD
Trazodone—Vertigo—Epirubicin—peripheral nervous system neoplasm	9.23e-05	0.000439	CcSEcCtD
Trazodone—Syncope—Epirubicin—peripheral nervous system neoplasm	9.22e-05	0.000438	CcSEcCtD
Trazodone—Back pain—Doxorubicin—peripheral nervous system neoplasm	9.2e-05	0.000438	CcSEcCtD
Trazodone—Palpitations—Epirubicin—peripheral nervous system neoplasm	9.08e-05	0.000432	CcSEcCtD
Trazodone—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	9.03e-05	0.00043	CcSEcCtD
Trazodone—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	8.96e-05	0.000426	CcSEcCtD
Trazodone—Nausea—Etoposide—peripheral nervous system neoplasm	8.89e-05	0.000423	CcSEcCtD
Trazodone—Hypertension—Epirubicin—peripheral nervous system neoplasm	8.87e-05	0.000422	CcSEcCtD
Trazodone—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	8.82e-05	0.00042	CcSEcCtD
Trazodone—Anaemia—Doxorubicin—peripheral nervous system neoplasm	8.79e-05	0.000418	CcSEcCtD
Trazodone—Arthralgia—Epirubicin—peripheral nervous system neoplasm	8.75e-05	0.000416	CcSEcCtD
Trazodone—Chest pain—Epirubicin—peripheral nervous system neoplasm	8.75e-05	0.000416	CcSEcCtD
Trazodone—Myalgia—Epirubicin—peripheral nervous system neoplasm	8.75e-05	0.000416	CcSEcCtD
Trazodone—Agitation—Doxorubicin—peripheral nervous system neoplasm	8.74e-05	0.000416	CcSEcCtD
Trazodone—Anxiety—Epirubicin—peripheral nervous system neoplasm	8.72e-05	0.000415	CcSEcCtD
Trazodone—Discomfort—Epirubicin—peripheral nervous system neoplasm	8.65e-05	0.000411	CcSEcCtD
Trazodone—Malaise—Doxorubicin—peripheral nervous system neoplasm	8.58e-05	0.000408	CcSEcCtD
Trazodone—Dry mouth—Epirubicin—peripheral nervous system neoplasm	8.56e-05	0.000407	CcSEcCtD
Trazodone—Vertigo—Doxorubicin—peripheral nervous system neoplasm	8.54e-05	0.000406	CcSEcCtD
Trazodone—Syncope—Doxorubicin—peripheral nervous system neoplasm	8.53e-05	0.000406	CcSEcCtD
Trazodone—Confusional state—Epirubicin—peripheral nervous system neoplasm	8.46e-05	0.000402	CcSEcCtD
Trazodone—Palpitations—Doxorubicin—peripheral nervous system neoplasm	8.4e-05	0.0004	CcSEcCtD
Trazodone—Oedema—Epirubicin—peripheral nervous system neoplasm	8.39e-05	0.000399	CcSEcCtD
Trazodone—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	8.36e-05	0.000398	CcSEcCtD
Trazodone—Shock—Epirubicin—peripheral nervous system neoplasm	8.25e-05	0.000393	CcSEcCtD
Trazodone—Hypertension—Doxorubicin—peripheral nervous system neoplasm	8.21e-05	0.000391	CcSEcCtD
Trazodone—Tachycardia—Epirubicin—peripheral nervous system neoplasm	8.19e-05	0.000389	CcSEcCtD
Trazodone—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	8.11e-05	0.000386	CcSEcCtD
Trazodone—Chest pain—Doxorubicin—peripheral nervous system neoplasm	8.1e-05	0.000385	CcSEcCtD
Trazodone—Myalgia—Doxorubicin—peripheral nervous system neoplasm	8.1e-05	0.000385	CcSEcCtD
Trazodone—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	8.1e-05	0.000385	CcSEcCtD
Trazodone—Anxiety—Doxorubicin—peripheral nervous system neoplasm	8.07e-05	0.000384	CcSEcCtD
Trazodone—Discomfort—Doxorubicin—peripheral nervous system neoplasm	8e-05	0.00038	CcSEcCtD
Trazodone—Anorexia—Epirubicin—peripheral nervous system neoplasm	8e-05	0.00038	CcSEcCtD
Trazodone—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	7.92e-05	0.000377	CcSEcCtD
Trazodone—Hypotension—Epirubicin—peripheral nervous system neoplasm	7.84e-05	0.000373	CcSEcCtD
Trazodone—Confusional state—Doxorubicin—peripheral nervous system neoplasm	7.83e-05	0.000372	CcSEcCtD
Trazodone—Oedema—Doxorubicin—peripheral nervous system neoplasm	7.76e-05	0.000369	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	7.64e-05	0.000363	CcSEcCtD
Trazodone—Shock—Doxorubicin—peripheral nervous system neoplasm	7.64e-05	0.000363	CcSEcCtD
Trazodone—Insomnia—Epirubicin—peripheral nervous system neoplasm	7.59e-05	0.000361	CcSEcCtD
Trazodone—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	7.57e-05	0.00036	CcSEcCtD
Trazodone—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	7.53e-05	0.000358	CcSEcCtD
Trazodone—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	7.5e-05	0.000357	CcSEcCtD
Trazodone—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	7.48e-05	0.000356	CcSEcCtD
Trazodone—Somnolence—Epirubicin—peripheral nervous system neoplasm	7.46e-05	0.000355	CcSEcCtD
Trazodone—Anorexia—Doxorubicin—peripheral nervous system neoplasm	7.4e-05	0.000352	CcSEcCtD
Trazodone—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	7.29e-05	0.000347	CcSEcCtD
Trazodone—Hypotension—Doxorubicin—peripheral nervous system neoplasm	7.25e-05	0.000345	CcSEcCtD
Trazodone—Fatigue—Epirubicin—peripheral nervous system neoplasm	7.23e-05	0.000344	CcSEcCtD
Trazodone—Pain—Epirubicin—peripheral nervous system neoplasm	7.17e-05	0.000341	CcSEcCtD
Trazodone—Constipation—Epirubicin—peripheral nervous system neoplasm	7.17e-05	0.000341	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	7.07e-05	0.000336	CcSEcCtD
Trazodone—Insomnia—Doxorubicin—peripheral nervous system neoplasm	7.02e-05	0.000334	CcSEcCtD
Trazodone—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	6.97e-05	0.000331	CcSEcCtD
Trazodone—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	6.92e-05	0.000329	CcSEcCtD
Trazodone—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	6.91e-05	0.000329	CcSEcCtD
Trazodone—Somnolence—Doxorubicin—peripheral nervous system neoplasm	6.9e-05	0.000328	CcSEcCtD
Trazodone—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	6.86e-05	0.000326	CcSEcCtD
Trazodone—ABCB1—cerebellum—peripheral nervous system neoplasm	6.77e-05	0.00448	CbGeAlD
Trazodone—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	6.75e-05	0.000321	CcSEcCtD
Trazodone—Fatigue—Doxorubicin—peripheral nervous system neoplasm	6.69e-05	0.000318	CcSEcCtD
Trazodone—Urticaria—Epirubicin—peripheral nervous system neoplasm	6.66e-05	0.000317	CcSEcCtD
Trazodone—Pain—Doxorubicin—peripheral nervous system neoplasm	6.64e-05	0.000316	CcSEcCtD
Trazodone—Constipation—Doxorubicin—peripheral nervous system neoplasm	6.64e-05	0.000316	CcSEcCtD
Trazodone—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	6.63e-05	0.000315	CcSEcCtD
Trazodone—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	6.63e-05	0.000315	CcSEcCtD
Trazodone—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	6.4e-05	0.000304	CcSEcCtD
Trazodone—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	6.35e-05	0.000302	CcSEcCtD
Trazodone—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	6.18e-05	0.000294	CcSEcCtD
Trazodone—Urticaria—Doxorubicin—peripheral nervous system neoplasm	6.17e-05	0.000293	CcSEcCtD
Trazodone—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	6.14e-05	0.000292	CcSEcCtD
Trazodone—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	6.14e-05	0.000292	CcSEcCtD
Trazodone—Asthenia—Epirubicin—peripheral nervous system neoplasm	6.02e-05	0.000286	CcSEcCtD
Trazodone—Pruritus—Epirubicin—peripheral nervous system neoplasm	5.93e-05	0.000282	CcSEcCtD
Trazodone—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	5.74e-05	0.000273	CcSEcCtD
Trazodone—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	5.72e-05	0.000272	CcSEcCtD
Trazodone—Asthenia—Doxorubicin—peripheral nervous system neoplasm	5.57e-05	0.000265	CcSEcCtD
Trazodone—Dizziness—Epirubicin—peripheral nervous system neoplasm	5.55e-05	0.000264	CcSEcCtD
Trazodone—Pruritus—Doxorubicin—peripheral nervous system neoplasm	5.49e-05	0.000261	CcSEcCtD
Trazodone—Vomiting—Epirubicin—peripheral nervous system neoplasm	5.33e-05	0.000254	CcSEcCtD
Trazodone—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	5.31e-05	0.000253	CcSEcCtD
Trazodone—Rash—Epirubicin—peripheral nervous system neoplasm	5.29e-05	0.000252	CcSEcCtD
Trazodone—Dermatitis—Epirubicin—peripheral nervous system neoplasm	5.28e-05	0.000251	CcSEcCtD
Trazodone—Headache—Epirubicin—peripheral nervous system neoplasm	5.25e-05	0.00025	CcSEcCtD
Trazodone—Dizziness—Doxorubicin—peripheral nervous system neoplasm	5.13e-05	0.000244	CcSEcCtD
Trazodone—Nausea—Epirubicin—peripheral nervous system neoplasm	4.98e-05	0.000237	CcSEcCtD
Trazodone—Vomiting—Doxorubicin—peripheral nervous system neoplasm	4.93e-05	0.000235	CcSEcCtD
Trazodone—Rash—Doxorubicin—peripheral nervous system neoplasm	4.89e-05	0.000233	CcSEcCtD
Trazodone—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	4.89e-05	0.000233	CcSEcCtD
Trazodone—Headache—Doxorubicin—peripheral nervous system neoplasm	4.86e-05	0.000231	CcSEcCtD
Trazodone—Nausea—Doxorubicin—peripheral nervous system neoplasm	4.61e-05	0.000219	CcSEcCtD
Trazodone—ADRA2A—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	6.79e-06	0.00117	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—GNAS—peripheral nervous system neoplasm	6.65e-06	0.00115	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	6.59e-06	0.00114	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—NME1—peripheral nervous system neoplasm	6.58e-06	0.00114	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.56e-06	0.00113	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—HGF—peripheral nervous system neoplasm	6.33e-06	0.00109	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—COX2—peripheral nervous system neoplasm	6.33e-06	0.00109	CbGpPWpGaD
Trazodone—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	6.33e-06	0.00109	CbGpPWpGaD
Trazodone—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	6.32e-06	0.00109	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—NTS—peripheral nervous system neoplasm	6.3e-06	0.00109	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	6.29e-06	0.00109	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—NTS—peripheral nervous system neoplasm	6.29e-06	0.00109	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—GNS—peripheral nervous system neoplasm	6.29e-06	0.00109	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.18e-06	0.00107	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—NTS—peripheral nervous system neoplasm	6.17e-06	0.00107	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	6.11e-06	0.00106	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	6.08e-06	0.00105	CbGpPWpGaD
Trazodone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	6.05e-06	0.00105	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CD55—peripheral nervous system neoplasm	6.04e-06	0.00104	CbGpPWpGaD
Trazodone—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	6.04e-06	0.00104	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CD55—peripheral nervous system neoplasm	6.03e-06	0.00104	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—NME1—peripheral nervous system neoplasm	6.03e-06	0.00104	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	5.98e-06	0.00103	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.98e-06	0.00103	CbGpPWpGaD
Trazodone—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	5.93e-06	0.00102	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CD55—peripheral nervous system neoplasm	5.92e-06	0.00102	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—COX2—peripheral nervous system neoplasm	5.8e-06	0.001	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—NTS—peripheral nervous system neoplasm	5.74e-06	0.000991	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	5.55e-06	0.000959	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—VIP—peripheral nervous system neoplasm	5.53e-06	0.000956	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	5.52e-06	0.000954	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	5.5e-06	0.000951	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—VIP—peripheral nervous system neoplasm	5.5e-06	0.000951	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CD55—peripheral nervous system neoplasm	5.5e-06	0.00095	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	5.34e-06	0.000924	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	5.32e-06	0.000919	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	5.28e-06	0.000913	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	5.27e-06	0.000911	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—ENO2—peripheral nervous system neoplasm	5.27e-06	0.000911	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	5.17e-06	0.000894	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	5.1e-06	0.000882	CbGpPWpGaD
Trazodone—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	5.1e-06	0.000882	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	5.08e-06	0.000878	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	5e-06	0.000864	CbGpPWpGaD
Trazodone—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	4.95e-06	0.000855	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	4.85e-06	0.000839	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	4.83e-06	0.000835	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	4.8e-06	0.00083	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	4.79e-06	0.000829	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	4.78e-06	0.000827	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—VIP—peripheral nervous system neoplasm	4.78e-06	0.000826	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—VIP—peripheral nervous system neoplasm	4.77e-06	0.000824	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	4.74e-06	0.00082	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.73e-06	0.000817	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	4.7e-06	0.000812	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—VIP—peripheral nervous system neoplasm	4.68e-06	0.000809	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—PTPN11—peripheral nervous system neoplasm	4.62e-06	0.000798	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	4.62e-06	0.000798	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	4.61e-06	0.000796	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	4.55e-06	0.000786	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	4.52e-06	0.000782	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	4.47e-06	0.000773	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—BCHE—peripheral nervous system neoplasm	4.45e-06	0.000769	CbGpPWpGaD
Trazodone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	4.43e-06	0.000766	CbGpPWpGaD
Trazodone—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	4.42e-06	0.000764	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	4.41e-06	0.000762	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	4.4e-06	0.000761	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	4.38e-06	0.000757	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	4.36e-06	0.000754	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—VIP—peripheral nervous system neoplasm	4.35e-06	0.000751	CbGpPWpGaD
Trazodone—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	4.34e-06	0.00075	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	4.32e-06	0.000746	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	4.28e-06	0.000741	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.25e-06	0.000734	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	4.2e-06	0.000726	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	4.19e-06	0.000725	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—TH—peripheral nervous system neoplasm	4.19e-06	0.000723	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	4.18e-06	0.000723	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.16e-06	0.000719	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—ENO2—peripheral nervous system neoplasm	4.16e-06	0.000718	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	4.12e-06	0.000713	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	4.11e-06	0.00071	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.04e-06	0.000699	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.04e-06	0.000699	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	4.01e-06	0.000693	CbGpPWpGaD
Trazodone—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.98e-06	0.000688	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	3.9e-06	0.000674	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.85e-06	0.000666	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.83e-06	0.000663	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	3.81e-06	0.000659	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.81e-06	0.000659	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—ENO2—peripheral nervous system neoplasm	3.81e-06	0.000658	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.54e-06	0.000611	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—BCHE—peripheral nervous system neoplasm	3.51e-06	0.000607	CbGpPWpGaD
Trazodone—ADRA2A—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	3.48e-06	0.000602	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—GNAS—peripheral nervous system neoplasm	3.42e-06	0.000591	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.37e-06	0.000583	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.36e-06	0.00058	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—ABCB1—peripheral nervous system neoplasm	3.35e-06	0.00058	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.35e-06	0.000579	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.31e-06	0.000572	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.3e-06	0.000571	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—TH—peripheral nervous system neoplasm	3.3e-06	0.000571	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.28e-06	0.000567	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.26e-06	0.000564	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.24e-06	0.00056	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	3.22e-06	0.000556	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	3.2e-06	0.000554	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.12e-06	0.00054	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.11e-06	0.000537	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.07e-06	0.000531	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	3.03e-06	0.000523	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.01e-06	0.000521	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	2.92e-06	0.000505	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.91e-06	0.000504	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.91e-06	0.000503	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	2.87e-06	0.000497	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.87e-06	0.000496	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.85e-06	0.000493	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.85e-06	0.000493	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.83e-06	0.00049	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.83e-06	0.000489	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	2.8e-06	0.000484	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—NRAS—peripheral nervous system neoplasm	2.78e-06	0.00048	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.77e-06	0.000479	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	2.71e-06	0.000468	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	2.7e-06	0.000468	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.7e-06	0.000467	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	2.7e-06	0.000466	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—GNAS—peripheral nervous system neoplasm	2.69e-06	0.000466	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.69e-06	0.000466	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.65e-06	0.000458	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—ABCB1—peripheral nervous system neoplasm	2.64e-06	0.000457	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.64e-06	0.000457	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.58e-06	0.000445	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.5e-06	0.000432	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.48e-06	0.000428	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.47e-06	0.000427	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	2.47e-06	0.000427	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.46e-06	0.000425	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.46e-06	0.000425	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	2.43e-06	0.00042	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.43e-06	0.000419	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	2.42e-06	0.000419	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.32e-06	0.0004	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	2.29e-06	0.000395	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	2.28e-06	0.000395	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.25e-06	0.00039	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.18e-06	0.000377	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	2.15e-06	0.000372	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—TP53—peripheral nervous system neoplasm	2.12e-06	0.000367	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—HRAS—peripheral nervous system neoplasm	2.03e-06	0.000351	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.03e-06	0.000351	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.02e-06	0.000349	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.99e-06	0.000344	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.98e-06	0.000343	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.94e-06	0.000336	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	1.86e-06	0.000322	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.83e-06	0.000316	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—AKT1—peripheral nervous system neoplasm	1.79e-06	0.00031	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.78e-06	0.000308	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	1.77e-06	0.000306	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.76e-06	0.000305	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	1.76e-06	0.000304	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.75e-06	0.000303	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.75e-06	0.000302	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.72e-06	0.000298	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.72e-06	0.000298	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.72e-06	0.000297	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.72e-06	0.000297	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.69e-06	0.000291	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.62e-06	0.000279	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.59e-06	0.000276	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.57e-06	0.000272	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.57e-06	0.000271	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.57e-06	0.000271	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	1.5e-06	0.000259	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.48e-06	0.000256	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.48e-06	0.000255	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.48e-06	0.000255	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.44e-06	0.000249	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.44e-06	0.000248	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.43e-06	0.000247	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.43e-06	0.000247	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.42e-06	0.000246	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	1.41e-06	0.000243	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.38e-06	0.000238	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.36e-06	0.000235	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.36e-06	0.000235	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.33e-06	0.00023	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.31e-06	0.000226	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.3e-06	0.000225	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.28e-06	0.000222	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.28e-06	0.000221	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.26e-06	0.000217	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.25e-06	0.000215	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.24e-06	0.000215	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.24e-06	0.000214	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.23e-06	0.000213	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.23e-06	0.000213	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.22e-06	0.000211	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.21e-06	0.000209	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.2e-06	0.000207	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.19e-06	0.000206	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.17e-06	0.000202	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	1.15e-06	0.000198	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.13e-06	0.000196	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.13e-06	0.000196	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.13e-06	0.000195	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.13e-06	0.000195	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	1.13e-06	0.000195	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.12e-06	0.000194	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.12e-06	0.000193	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.11e-06	0.000192	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.11e-06	0.000192	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.08e-06	0.000187	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.03e-06	0.000179	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.03e-06	0.000179	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.03e-06	0.000178	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.01e-06	0.000175	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.64e-07	0.000167	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.62e-07	0.000166	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.54e-07	0.000165	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.44e-07	0.000163	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.42e-07	0.000163	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—AKT1—peripheral nervous system neoplasm	9.22e-07	0.000159	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	9.16e-07	0.000158	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	9.12e-07	0.000158	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.77e-07	0.000152	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.76e-07	0.000152	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.72e-07	0.000151	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.92e-07	0.000137	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.9e-07	0.000137	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.75e-07	0.000134	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.74e-07	0.000134	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.7e-07	0.000133	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.57e-07	0.000131	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.56e-07	0.000131	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.41e-07	0.000128	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—AKT1—peripheral nervous system neoplasm	7.27e-07	0.000126	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.2e-07	0.000125	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.89e-07	0.000119	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.69e-07	0.000116	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.67e-07	0.000115	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	6.67e-07	0.000115	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.55e-07	0.000113	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.08e-07	0.000105	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	5.03e-07	8.7e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	4.74e-07	8.19e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	3.1e-07	5.36e-05	CbGpPWpGaD
